Evidence map›Paper›PMID 29515639›Full record

ArticleIranian journal of pathology2017

Conserved OprF as a Selective Immunogen against

Ehsan Kazemi Moghaddam, Parviz Owlia, Abolfazl Jahangiri, Iraj Rasooli, Mohammad Reza Rahbar, Marjan Aghajani

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. EPY001, a Novel Monoclonal Antibody AgainstInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ehsan Kazemi MoghaddamDept. of Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran.
Parviz OwliaMolecular Microbiology Research Center, Faculty of Medicine, Shahed University, Tehran, Iran.
Abolfazl JahangiriApplied Microbiology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Iraj RasooliDept. of Biology, Faculty of Basic Sciences, Shahed University, Tehran, Iran.
Mohammad Reza RahbarPharmaceutical Sciences Research Center, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Marjan AghajaniDept. of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Shahed University · IRBaqiyatallah University of Medical Sciences · IRShiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

objectivesDue to the importance of

methodsThe databank of NCBI was used to retrieve protein sequences recorded for OprF in

resultsOf these, 134 strains were isolated from clinical specimens and other strains from environmental samples. Evaluation of alignment by the mentioned software clearly showed that this protein was conserved. Antigenicity and grand average of hydropathicity were favorable.

conclusionConservation of OprF in all pathogenic and environmental strains of

Indexed as

OprF ProteinPseudomonas aeruginosaVaccine

Identifiers

PMID29515639
PMCPMC5831073
OpenAlexW2696426204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.